Loading…
Patient Access to ESRD New Innovative Devices Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
51pct
1d open
vs 9,062 other HR bills in the 116th — cohort avg 39d
Patient Access to ESRD New Innovative Devices Act This bill requires the Centers for Medicare & Medicaid Services (CMS) to establish a process to provide a certain payment adjustment under the Medicare end-stage renal disease (ESRD) prospective payment system. Specifically, the CMS must establish a process to provide for an add-on payment adjustment for new medical devices used to diagnose, treat, or manage ESRD.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (6)
2020 · fourth_quarter · Medicare/Medicaid
Referred to the Subcommittee on Health.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Discuss issues related to the Medicare bundled payment for renal disease, including H.R. 2710, the Patient Access to ESRD New Innovative Devices Act; monitor COVID-19 response bills and how they impacted kidney care for patients.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Medicare/Medicaid
HR 2710/S2751, Patient Access to ESRD New Innovative Devices Act, new tech innovation and increased access to home dialysis. CARES Act, P.L. 116-136, as it relates to home dialysis during public health emergency.
Client expense: $410,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE
2020 · fourth_quarter · Medicare/Medicaid
Funding issues for Medicare Part B 340 B drug discount program Dialysis reimbursement H.R.2710 - Patient Access to ESRD New Innovative Devices Act
Client expense: Not reported · Firm income: $30,000
Government targets: Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Medicare/Medicaid
Issues related to End Stage Renal Disease; Acute Kidney Injury; Dialysis. S. 1676 - Chronic Kidney Disease Improvement in Research and Treatment Act of 2019. H.R. 2710 - Patient Access to ESRD New Innovative Devices Act. ESRD Treatment Choices Model. Issues related to Medicare Advantage; Better Kidney Care Act. H.R. 266, Paycheck Protection Program and Health Care Enhancement Act H.R. 6800, HEROES Act H.R. 748, Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 133, Consolidated Appropriations Act, 2021
Client expense: Not reported · Firm income: $80,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2020 · fourth_quarter · Health Issues
Monitored issues related to pharmaceutical prices. Issues related to ESRD / PPS transitional technology add-on payment adjustment for new and innovative equipment and supplies. H.R. 2710 / S.2751, Patient Access to ESRD New Innovative Devices Act, S. 1895, Lower Health Care Costs Act of 2019; S. 2543, Prescription Drug Pricing Reduction Act of 2019; Issues involving drug shortages. Issues regarding the strategic national stockpile. Issues related to home dialysis and the Presidents Advancing American Kidney Health Initiative (AAKHI), and the ESRD Treatment Choices model. H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act. H.R. 925 / H.R. 8406, The HEROES Act. Monitored S. 4317, SAFE TO WORK Act. Monitored S. 4322, Safely Back to School and Back to Work Act. H.R. 133, The Consolidated Appropriations Act of 2021.
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2020 · fourth_quarter · Medicare/Medicaid
Issues related to ESRD PPS and innovative device reimbursement policies. H.R. 2710 / S. 2751, Patient Access to ESRD New Innovative Devices Act. Issues regarding dialysis in the home and the Presidents Advancing American Kidney Health Initiative (AAKHI).
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2020 · fourth_quarter · Medicare/Medicaid
ESRD, innovation, Medicare coverage and reimbursement, new tech add-on, kidney care demonstrations Kidney Rx home dialysis H.R. 2710, Patient Access to ESRD New Innovative Devices Act H.R. 133 - Consolidated Appropriations Act, 2021
Client expense: Not reported · Firm income: $80,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2020 · second_quarter · Medicare/Medicaid
HR 2710/S2751, Patient Access to ESRD New Innovative Devices Act, new tech innovation and increased access to home dialysis. CARES Act, P.L. 116-136, as it relates to home dialysis during public health emergency.
Client expense: $370,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
2020 · third_quarter · Medicare/Medicaid
Issues related to End Stage Renal Disease; Acute Kidney Injury; Dialysis. S. 1676 - Chronic Kidney Disease Improvement in Research and Treatment Act of 2019. H.R. 2710 - Patient Access to ESRD New Innovative Devices Act. ESRD Treatment Choices Model. Issues related to Medicare Advantage; Better Kidney Care Act. H.R. 6074, the Coronavirus Preparedness and Response Supplemental Appropriations Act - Public Law No: 116-123 H.R. 6201, the Families First Coronavirus Response Act - Public Law No: 116-127 H.R. 748, the Coronavirus Aid, Relief, and Economic Security (CARES) Act - Public Law No: 116-136 H.R. 266, Paycheck Protection Program and Health Care Enhancement Act H.R. 6800, HEROES Act H.R. 748, Coronavirus Aid, Relief, and Economic Security (CARES) Act
Client expense: Not reported · Firm income: $80,000
2020 · third_quarter · Health Issues
Monitored issues related to pharmaceutical prices. Issues related to ESRD / PPS transitional technology add-on payment adjustment for new and innovative equipment and supplies. H.R. 2710 / S.2751, Patient Access to ESRD New Innovative Devices Act, S. 1895, Lower Health Care Costs Act of 2019; S. 2543, Prescription Drug Pricing Reduction Act of 2019; Issues involving drug shortages and product sterilization. Issues regarding the strategic national stockpile. Issues related to home dialysis and the Presidents Advancing American Kidney Health Initiative (AAKHI), and the ESRD Treatment Choices model. H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act. H.R. 925 / H.R. 8406, The HEROES Act. Monitored S. 4317, SAFE TO WORK Act. Monitored S. 4322, Safely Back to School and Back to Work Act.
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2020 · third_quarter · Medicare/Medicaid
Issues related to ESRD PPS and innovative device reimbursement policies. H.R. 2710 / S. 2751, Patient Access to ESRD New Innovative Devices Act. Issues regarding dialysis in the home and the Presidents Advancing American Kidney Health Initiative (AAKHI).
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2020 · third_quarter · Medicare/Medicaid
Discuss issues related to the Medicare bundled payment for renal disease, including H.R. 2710, the Patient Access to ESRD New Innovative Devices Act; monitor COVID-19 response bills and how they impacted kidney care for patients.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Medicare/Medicaid
HR 2710/S2751, Patient Access to ESRD New Innovative Devices Act, new tech innovation and increased access to home dialysis. CARES Act, P.L. 116-136, as it relates to home dialysis during public health emergency.
Client expense: $550,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
2020 · third_quarter · Medicare/Medicaid
Funding issues for Medicare Part B 340 B drug discount program Dialysis reimbursement H.R.2710 - Patient Access to ESRD New Innovative Devices Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES
2020 · third_quarter · Medicare/Medicaid
ESRD, innovation, Medicare coverage and reimbursement, new tech add-on, kidney care demonstrations Kidney Rx home dialysis H.R. 2710, Patient Access to ESRD New Innovative Devices Act
Client expense: Not reported · Firm income: $80,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2020 · second_quarter · Medicare/Medicaid
Discuss issues related to the Medicare bundled payment for renal disease, including H.R. 2710, the Patient Access to ESRD New Innovative Devices Act; monitor COVID-19 response bills and how they impacted kidney care for patients.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · second_quarter · Health Issues
Monitored issues related to pharmaceutical prices. Issues related to ESRD payment. H.R. 2710, Patient Access to ESRD New Innovative Devices Act. Monitored H.R. 2296, METRIC Act of 2019. S. 1895, Lower Health Care Costs Act of 2019; S. 2543, Prescription Drug Pricing Reduction Act of 2019; Issues involving drug shortages and product sterilization. Issues regarding the Strategic National Stockpile inventory. Issues related to home dialysis and the Presidents Advancing American Kidney Health initiative (AAKHI). Issues regarding urgent start dialysis.
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE
2020 · second_quarter · Medicare/Medicaid
Issues related to ESRD PPS and innovative device reimbursement policies. H.R. 2710, Patient Access to ESRD New Innovative Devices Act. Issues regarding dialysis in the home and the Presidents Advancing American Kidney Health initiative (AAKHI). Issues regarding urgent start dialysis.
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE
2020 · second_quarter · Medicare/Medicaid
HR 2710/S2751, Patient Access to ESRD New Innovative Devices Act, new tech innovation and increased access to home dialysis. CARES Act, P.L. 116-136, as it relates to home dialysis during public health emergency.
Client expense: $370,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
2020 · second_quarter · Medicare/Medicaid
Funding issues for Medicare Part B 340 B drug discount program Dialysis reimbursement H.R.2710 - Patient Access to ESRD New Innovative Devices Act
Client expense: Not reported · Firm income: $30,000
Government targets: Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Treasury, Dept of
2020 · second_quarter · Medicare/Medicaid
ESRD, innovation, Medicare coverage and reimbursement, new tech add-on, kidney care demonstrations Kidney Rx home dialysis H.R. 2710, Patient Access to ESRD New Innovative Devices Act
Client expense: Not reported · Firm income: $80,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2020 · second_quarter · Medicare/Medicaid
Issues related to End Stage Renal Disease; Acute Kidney Injury; Dialysis. S. 1676 - Chronic Kidney Disease Improvement in Research and Treatment Act of 2019. H.R. 2710 - Patient Access to ESRD New Innovative Devices Act. ESRD Treatment Choices Model. Issues related to Medicare Advantage; Better Kidney Care Act. H.R. 6074, the Coronavirus Preparedness and Response Supplemental Appropriations Act - Public Law No: 116-123 H.R. 6201, the Families First Coronavirus Response Act - Public Law No: 116-127 H.R. 748, the Coronavirus Aid, Relief, and Economic Security (CARES) Act - Public Law No: 116-136 H.R. 266, Paycheck Protection Program and Health Care Enhancement Act H.R. 6800, HEROES Act H.R. 748, Coronavirus Aid, Relief, and Economic Security (CARES) Act
Client expense: Not reported · Firm income: $80,000
2020 · first_quarter · Medicare/Medicaid
Discuss issues related to the Medicare bundled payment for renal disease, including H.R. 2710, the Patient Access to ESRD New Innovative Devices Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · first_quarter · Medicare/Medicaid
Issues related to ESRD PPS and innovative device reimbursement policies. H.R. 2710, Patient Access to ESRD New Innovative Devices Act. Issues regarding dialysis in the home. Coronavirus Aid, Relief & Economic Security Act "CARES Act," P.L. 116-136, as it relates to home dialysis and urgent start dialysis.
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, Veterans Affairs, Dept of (VA)
2020 · first_quarter · Health Issues
Monitored issues related to pharmaceutical prices. Issues related to ESRD payment. H.R. 2710, Patient Access to ESRD New Innovative Devices Act. Monitored H.R. 2296, METRIC Act of 2019. S. 1895, Lower Health Care Costs Act of 2019; S. 2543, Prescription Drug Pricing Reduction Act of 2019; Issues involving drug shortages and product sterilization. Issues regarding the Strategic National Stockpile inventory. Issues related to home dialysis. Coronavirus Aid, Relief & Economic Security Act "CARES Act," P.L. 116-136, as it relates to home dialysis and urgent start dialysis.
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, Veterans Affairs, Dept of (VA)
2020 · first_quarter · Medicare/Medicaid
HR 2710/S2751, Patient Access to ESRD New Innovative Devices Act, new tech innovation and increased access to home dialysis. CARES Act, P.L. 116-136, as it relates to home dialysis during public health emergency.
Client expense: $500,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
2020 · first_quarter · Medicare/Medicaid
Funding issues for Medicare Part B 340 B drug discount program Dialysis reimbursement H.R.2710 - Patient Access to ESRD New Innovative Devices Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
2020 · first_quarter · Medicare/Medicaid
Issues related to End Stage Renal Disease; Acute Kidney Injury; Dialysis. S. 1676 - Chronic Kidney Disease Improvement in Research and Treatment Act of 2019. H.R. 2710 - Patient Access to ESRD New Innovative Devices Act. ESRD Treatment Choices Model. Issues related to Medicare Advantage; Better Kidney Care Act. H.R. 6074, the Coronavirus Preparedness and Response Supplemental Appropriations Act - Public Law No: 116-123 H.R. 6201, the Families First Coronavirus Response Act - Public Law No: 116-127 H.R. 748, the Coronavirus Aid, Relief, and Economic Security (CARES) Act - Public Law No: 116-136
Client expense: Not reported · Firm income: $80,000
2020 · first_quarter · Medicare/Medicaid
ESRD, innovation, Medicare coverage and reimbursement, new tech add-on, kidney care demonstrations Kidney Rx home dialysis H.R. 2710, Patient Access to ESRD New Innovative Devices Act
Client expense: Not reported · Firm income: $80,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2019 · fourth_quarter · Medicare/Medicaid
Discuss issues related to the Medicare bundled payment for renal disease, including H.R. 2710, the Patient Access to ESRD New Innovative Devices Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · fourth_quarter · Medicare/Medicaid
Issues related to ESRD PPS and innovative device reimbursement policies. H.R. 2710, Patient Access to ESRD New Innovative Devices Act. Issues regarding dialysis in the home.
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
2019 · fourth_quarter · Health Issues
Monitored issues related to pharmaceutical prices. Issues related to ESRD payment. H.R. 2710, Patient Access to ESRD New Innovative Devices Act. Monitored H.R. 2296, METRIC Act of 2019. S. 1895, Lower Health Care Costs Act of 2019; S. 2543, Prescription Drug Pricing Reduction Act of 2019; Issues involving drug shortages. Issues regarding the Strategic National Stockpile inventory. Issues related to home dialysis.
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
2019 · fourth_quarter · Medicare/Medicaid
ESRD new tech innovation and increased access home dialysis. HR 2710/S 2751, Patient Access to ESRD New Innovative Devices Act, regarding all provisions.
Client expense: $400,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2019 · fourth_quarter · Medicare/Medicaid
Funding issues for Medicare Part B 340 B drug discount program Dialysis reimbursement H.R.2710 - Patient Access to ESRD New Innovative Devices Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES
2019 · fourth_quarter · Medicare/Medicaid
ESRD, innovation, Medicare coverage and reimbursement, new tech add-on, kidney care demonstrations Kidney Rx home dialysis H.R. 2710, Patient Access to ESRD New Innovative Devices Act
Client expense: Not reported · Firm income: $80,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2019 · fourth_quarter · Medicare/Medicaid
Issues related to End Stage Renal Disease; Acute Kidney Injury; Dialysis. S. 1676 - Chronic Kidney Disease Improvement in Research and Treatment Act of 2019. H.R. 2710 - Patient Access to ESRD New Innovative Devices Act. ESRD Treatment Choices Model.
Client expense: Not reported · Firm income: $80,000
2019 · third_quarter · Medicare/Medicaid
Discuss issues related to the Medicare bundled payment for renal disease, including H.R. 2710, the Patient Access to ESRD New Innovative Devices Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · third_quarter · Health Issues
Monitored issues related to pharmaceutical prices. Issues related to ESRD payment. H.R. 2710, Patient Access to ESRD New Innovative Devices Act. Monitored H.R. 2296, METRIC Act of 2019. S. 1895, Lower Health Care Costs Act of 2019; S. 2593, Prescription Drug Pricing Reduction Act of 2019; Issues involving drug shortages. Issues regarding the Strategic National Stockpile inventory. Issues related to home dialysis.
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2019 · third_quarter · Medicare/Medicaid
Issues related to ESRD PPS and innovative device reimbursement policies. H.R. 2710, Patient Access to ESRD New Innovative Devices Act. Issues regarding dialysis in the home.
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2019 · third_quarter · Medicare/Medicaid
ESRD new tech innovation and increased access home dialysis. HR 2710, Patient Access to ESRD New Innovative Devices Act, regarding all provisions.
Client expense: $500,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2019 · third_quarter · Medicare/Medicaid
Funding issues for Medicare Part B 340 B drug discount program Dialysis reimbursement H.R.2710 - Patient Access to ESRD New Innovative Devices Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · third_quarter · Medicare/Medicaid
Issues related to End Stage Renal Disease; Acute Kidney Injury; Dialysis. S. 1676 - Chronic Kidney Disease Improvement in Research and Treatment Act of 2019. H.R. 2710 - Patient Access to ESRD New Innovative Devices Act. ESRD Treatment Choices Model.
Client expense: Not reported · Firm income: $80,000
2019 · third_quarter · Medicare/Medicaid
ESRD, innovation, Medicare coverage and reimbursement, new tech add-on Kidney Rx home dialysis H.R. 2710, Patient Access to ESRD New Innovative Devices Act
Client expense: Not reported · Firm income: $80,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2019 · second_quarter · Medicare/Medicaid
Discuss issues related to the Medicare bundled payment for renal disease, including H.R. 2710, the Patient Access to ESRD New Innovative Devices Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · second_quarter · Medicare/Medicaid
Funding issues for Medicare Part B 340 B drug discount program Dialysis reimbursement H.R.2710 - Patient Access to ESRD New Innovative Devices Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · second_quarter · Medicare/Medicaid
ESRD new tech innovation and increased access home dialysis. HR 2710, Patient Access to ESRD New Innovative Devices Act, regarding all provisions.
Client expense: $560,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2019 · second_quarter · Health Issues
Monitored issues related to pharmaceutical prices. Monitored H.R. 2296, METRIC Act of 2019. Issues related to ESRD payment. H.R. 2710, Patient Access to ESRD New Innovative Devices Act. Issues related to Pandemic and All-Hazards Preparedness. S. 1379 / H.R. 269, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 (PAHPA). S. 1895, Lower Health Care Costs Act of 2019. Issues involving drug shortages. Issues regarding the Strategic National Stockpile inventory. Issues related to home dialysis.
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2019 · second_quarter · Medicare/Medicaid
Issues related to ESRD PPS and innovative device reimbursement policies. H.R. 2710, Patient Access to ESRD New Innovative Devices Act. Issues regarding dialysis in the home.
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2019 · second_quarter · Medicare/Medicaid
Issues related to End Stage Renal Disease; Acute Kidney Injury; Dialysis. S. 1676 - Chronic Kidney Disease Improvement in Research and Treatment Act of 2019 H.R. 2710 - Patient Access to ESRD New Innovative Devices Act
Client expense: Not reported · Firm income: $80,000
| Republican |
| IN |
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE